In recent years there have been many advances in the production of recombinant proteins in bacterial hosts. A common problem is the sequestration of recombinant protein by the bacterium in an inclusion body which is the general term for a large insoluble protein aggregate. Harsh denaturing conditions are typically needed to solubilize the inclusion body protein with a consequent requirement of refolding to obtain functional protein. Despite these difficulties, inclusion bodies have some attractive features for recombinant protein production including each cell having one inclusion body which contains high purity protein and as much as 50% of the total mass of cellular protein.
In recent years there have been many advances in the production of recombinant proteins in bacterial hosts. A common problem is the sequestration of recombinant protein by the bacterium in an inclusion body which is the general term for a large insoluble protein aggregate. Harsh denaturing conditions are typically needed to solubilize the inclusion body protein with a consequent requirement of refolding to obtain functional protein. Despite these difficulties, inclusion bodies have some attractive features for recombinant protein production including each cell having one inclusion body which contains high purity protein and as much as 50% of the total mass of cellular protein. 1 Inclusion bodies are noncrystalline solids and there has been little high-resolution, residue-specific study to ascertain their molecular structure. The most common structural method has been infrared (IR) spectroscopy which provided information about the overall fractions of different types of regular secondary structure. These studies were typically carried out on dehydrated samples and suggested that there was more sheet structure in the inclusion body protein than in the native fold. It was therefore proposed that the non-native strands from different proteins associated together to form intermolecular -sheets in a structure similar to amyloid protein. [2] [3] [4] [5] [6] [7] [8] Some reports indicate that a fraction of inclusion body protein is natively folded and functional. 3, 9 This paper describes application of solid-state NMR to determine residue-specific secondary structure in inclusion body protein. The methods are straightforward and inexpensive and should be broadly applicable to a wide variety of proteins in inclusion bodies. The methods were initially developed to study residue-specific conformation in membrane-reconstituted proteins and were based on the observation that in sequences of proteins of moderate size, a large fraction of the residues are in "unique sequential pairs", for example, there would only be one instance of a Leu followed by a Leu. In addition, NMR methods such as "rotational-echo double-resonance" (REDOR) can selectively detect the signal of the 13 C carbonyl ( 13 CO) nuclei which are directly bonded to 15 N nuclei, and there are well-known correlations between the backbone 13 CO NMR chemical shift of a residue and its local conformation. [10] [11] [12] Recombinant protein was therefore produced in E. coli cells in minimal media containing the 1-13 C amino acid and 15 N-amino acid of the respective N-and C-terminal residues of the unique sequential pair, and the filtered 13 CO NMR signal of the N-terminal residue of the pair was used to determine its conformation. 12 These methods were first applied to "FHA2" which is a N-terminal 185-residue functional domain of the 221-residue "HA2" subunit of the influenza virus hemagglutinin protein.
12 FHA2 contains a ∼20-residue N-terminal "fusion peptide" that binds to the host cell membrane and plays a key role in infection. FHA2 is a membrane protein because of the fusion peptide while shorter constructs which lack the fusion peptide are soluble in aqueous solution and have been crystallized. 13 There is also a NMR structure of the HA2 fusion peptide in detergent micelles. 14 One essential feature of the method was expression in minimal media containing labeled amino acids. However, growth only in minimal media provided <0.5 mg purified FHA2 per L culture and an alternate protocol was developed to first grow to high cell densities in rich media and to then switch to minimal media prior to expression. 12, 15, 16 Using this method, the purified yield of FHA2 from the soluble cell lysate was ∼10 mg/L culture. This was likely the fraction of FHA2 which was incorporated in cell membranes because the lysis buffer contained N-lauroylsarcosine detergent which is effective at solubilizing membrane proteins.
There was a significant amount of FHA2 in inclusion bodies as evidenced by a dominant FHA2 band in the SDS-PAGE gels of the unlysed fully hydrated E. coli cells and in the hydrated pellet formed from centrifugation of the insoluble material in the cell lysate, Figure 1a . In addition, ∼10 mg/L more FHA2 was purified after sonication of the aforementioned pellet in 8 M urea, and this denatured FHA2 could be refolded in detergent and reconstituted in membranes. 16 The relative band intensities in Figure 1a suggest that FHA2 is at least 10-20% of the total protein mass in the insoluble fraction and in unlysed whole cells and in the present study, the labeling/solid-state NMR method was applied to FHA2 in these two hydrated materials. 17, 18 The 13 CO NMR signals were dominated by FHA2 as evidenced by comparison of the "S 0 " (black) and "S 1 " (red) REDOR NMR spectra of the pellet for which the labeling targeted the Leu-98/Leu-99 unique sequential pair, Figure  1b . The S 0 spectrum was composed of all the 13 CO signal in the sample whereas the S 1 spectrum lacked signal from 13 CO nuclei directly bonded to 15 N nuclei. The experimental S 1 /S 0 integrated intensity ratio was 0.89 and correlated with the 0.92 ratio expected for fully labeled FHA2 with 13 Leus in the sequence. The experimental and (expected) ratios for labeling which targeted Gly-4 and Ala-7 were 0.93 (0.94) and 0.93 (0.91), respectively and were generally consistent with labeled amino acids being in the media only during the expression period and with FHA2 being the primary protein produced during the expression period.
The S 0 -S 1 REDOR difference spectrum primarily represents the filtered 13 CO signal of the N-terminal residue of the unique sequential pair and such spectra are presented in Figure 1 for (c, f, i) Gly-4, (d, g, j) Ala-7, or (e, h, k) Leu-98 and for FHA2 (c-e) purified and reconstituted in membranes, (f-h) in inclusion bodies in the insoluble cell lysate, or (i-k) in unlysed whole cells. There is general similarity of the spectra and peak 13 CO chemical shifts of the membrane-reconstituted, inclusion body, and whole cell FHA2 protein, Figure 1c -k and Table 1 . The similarity of the insoluble fraction and the whole cell spectra correlated with most of the FHA2 being in inclusion bodies. In the existing structures, a N-terminal helix extends to residue 10 in the fusion peptide and there is a helix that extends from residue 38 to residue 105. The peak 13 CO shifts for Gly-1, Gly-4, Ala-7, and Leu-98 correlate with these helical conformations as evidenced by better agreement with distributions of backbone 13 CO shifts in helical conformation (175.5 ( 1.2, 179.4 ( 1.3, and 178.5 ( 1.3 ppm for Gly, Ala, and Leu, respectively) than with characteristic shifts in sheet/amyloid samples(170-172,174-176,and173-175ppm,respectively). 5, 6, 11, 19, 20 The Ala-7 spectra of the insoluble fraction and whole cell samples are broader than the other spectra which may indicate some conformational heterogeneity at this residue. Overall, the data support a model in which native helical conformation is retained at least for a significant fraction of inclusion body FHA2. It is interesting that dominant sheet chemical shifts were not observed in the fusion peptide region because this region is hydrophobic and could potentially form amyloid aggregates in the absence of membranes. Although 13 CO shifts are not absolutely definitive in determining conformation and are correlated with regions of the Ramachandran plot rather than precise dihedral angles, 13 CO shifts do provide significant conformational information particularly when helical shifts at several nearby residues are obtained (as in the fusion peptide region) or when sharp signals (indicating structural order) with very similar helical shifts are obtained in both the natively folded and inclusion body protein (as with Leu-98). 11 The approach presented in this paper has two significant advantages over the more commonly used IR approach for study of inclusion body structure. First, conformation at individual residues is straightforwardly studied with the NMR method but only overall protein conformation is typically obtained with the IR method. It should therefore be possible to develop more detailed structural models with the NMR data. Second, the inclusion body and whole cell samples are fully hydrated with the NMR method rather than being dehydrated with the IR method. A large number of specifically labeled samples are required for a high-resolution NMR structural model of inclusion body protein but depending on linewidths, it may be possible to obtain structural data for samples with more significant labeling using methods previously applied to NMR structure determination of microcrystalline, amyloid, and membrane-associated proteins. 5, 6, [19] [20] [21] In summary, this study describes a general approach for residue-specific structural analysis of recombinant protein in inclusion bodies including those in whole E. coli cells as well as evidence for native conformation at some specific residues of a particular inclusion body protein. 13 C solidstate NMR spectra of FHA2. Panel b is for the insoluble fraction Leu-98 sample and the S 0 and S1 REDOR spectra are displayed in black and red, respectively. The remaining panels are S 0 -S1 difference spectra. Example expression media contained 1- NLeu (for Leu-98). The most complete labeling of inclusion body FHA2 was obtained with addition of 30 mg/L of each labeled amino acid at the start of induction and at the 1 and 2 h times during the 3 h induction period. Experimental NMR conditions included 9.4 T spectrometer, 40 µL active sample volume, and sample cooling gas at -20°C. Each membranereconstituted sample contained ∼5 mg FHA2 and each c-e spectrum was obtained in ∼3 days, while each of the other spectra was obtained in ∼1 1 /2 days. protein of the influenza virus, X31 strain, and the last 8 residues are non-native. The sequence is written in lines containing 50 residues and the Gly-1, Gly-4, Ala-7, and Leu-98 residues are in bold and underlined.
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Expression and labeling of FHA2
The protocol for expression and labeling of FHA2 in inclusion bodies was similar to that described for FHA2 incorporated in bacterial membranes and subsequently The cell yield with this protocol was typically 10 g cells/L culture.
Separation and native purification of the bacterial membrane fraction of FHA2 and reconstitution of this fraction in synthetic membranes
The protocol for separation and native purification of the fraction of FHA2 incorporated in bacterial membranes has been previously described, cf. Curtis-Fisk, J.; 
Preparation of inclusion body samples
Unlike the fraction of FHA2 incorporated in the bacterial membranes, the inclusion body FHA2 was not solubilized by the lysis buffer and was in the pellet obtained from centrifugation of the cell lysate at 50000g for 30 minutes. While optimizing the inclusion body protocol, pellets were also obtained with smaller centrifugation g forces and shorter times, but the SDS-PAGE gels of these pellets were very similar to the gel displayed in lane 3 of Fig. 1 in the main text. In addition, NMR samples were taken from different regions of the same pellet but the NMR spectra of these different samples were very similar. For the final protocol, the insoluble fraction NMR sample was taken from all regions of the pellet.
Solid-state nuclear magnetic resonance (NMR) experiments and analysis
Solid-state NMR rotational-echo double-resonance (REDOR) experiments were carried out using a 9.4 T spectrometer and a 4.0 mm MAS probe tuned to There will also be natural abundance contributions to the S 0 -S 1 difference signal.
A model is developed for these contributions in the context of the following approximations: (1) the recombinant protein makes up a large portion of the mass of the sample; and (2) only the recombinant protein is labeled and the labeling is close to 100%.
These approximations appeared to hold for the insoluble fraction of the cell lysate with FHA2 labeling which targeted the Gly-4 or Ala-7 residues. The recombinant protein is considered to have "D" residues that are In the context of the model, the lineshape of the natural abundance contribution to the S 0 -S 1 difference signal will primarily depend on the amino acid identities and the conformations of the residues in sequential pairs containing labeled residues. Because there will likely be a wide variety of amino acid types and perhaps conformations for these residues, there will likely be significant chemical shift dispersion in the lineshape.
For large values of D and E, the S 0 -S 1 difference signal would therefore appear to contain a sharp signal from the 13 CO in the unique sequential pair and a broad signal from the contributions described in the aforementioned model.
Each of the membrane-reconstituted samples contained ~5 mg FHA2 and the corresponding spectrum was obtained with ~3 days of signal averaging. The signal-tonoises of the insoluble fraction and whole cell samples were typically comparable or higher than that of the corresponding membrane-reconstituted sample and were obtained in ~1½ days, cf. Fig. 1 in the main manuscript. There may be variation in motion and hence cross-polarization and REDOR efficiencies for the different sample types which would differentially affect signal intensities, but neglecting this potential variation, the signal-to-noises in the spectra suggest that the insoluble fraction and whole cell NMR samples contained 5-10 mg FHA2. The NMR active sample volume was ~40 μL which could likely contain ~50 mg of material. The overall analysis therefore suggested that 10-20% of the mass in the insoluble fraction and whole cell NMR samples was FHA2 and this percentage was generally consistent with the apparent mass fraction of FHA2 in the gels in Fig. 1a of the main manuscript.
In the main manuscript, the reported distributions of 13 CO chemical shifts for Gly, Ala, and Leu residues in helical conformations were obtained from Table 7 
